{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:18:19Z","timestamp":1772482699334,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Project on Guangxi Key Research and Development Plan","award":["GK AB24010172"],"award-info":[{"award-number":["GK AB24010172"]}]},{"name":"Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under Grant","award":["2024GXNSFAA010315"],"award-info":[{"award-number":["2024GXNSFAA010315"]}]},{"name":"Beijing Meidical Award Foundation","award":["YXJL-2023-0866-0322"],"award-info":[{"award-number":["YXJL-2023-0866-0322"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01925-5","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T12:37:26Z","timestamp":1739104646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of magnetic resonance imaging-defined sarcopenia on prognosis in patients with locally advanced nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Yuanling","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizhen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zisan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,9]]},"reference":[{"issue":"10192","key":"1925_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)30956-0.","journal-title":"Lancet"},{"key":"1925_CR2","unstructured":"Ferlay J, EM, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer.\u00a0https:\/\/gco.iarc.who.int\/today. 2024; Accessed 17 Jul 2024."},{"issue":"12","key":"1925_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381(12):1124\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1905287.","journal-title":"N Engl J Med"},{"issue":"6","key":"1925_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.annonc.2020.03.289","volume":"31","author":"EP Hui","year":"2020","unstructured":"Hui EP, Li WF, Ma BB, Lam WKJ, Chan KCA, Mo F, et al. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. Ann Oncol. 2020;31(6):769\u201379. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.289.","journal-title":"Ann Oncol"},{"issue":"10191","key":"1925_CR5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/s0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9.","journal-title":"Lancet"},{"key":"1925_CR6","doi-asserted-by":"publisher","first-page":"175883592110088","DOI":"10.1177\/17588359211008844","volume":"13","author":"A Surov","year":"2021","unstructured":"Surov A, Wienke A. Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis. Ther Adv Med Oncol. 2021;13:17588359211008844. https:\/\/doi.org\/10.1177\/17588359211008844.","journal-title":"Ther Adv Med Oncol"},{"issue":"5","key":"1925_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/nu15051193","volume":"15","author":"AL Couderc","year":"2023","unstructured":"Couderc AL, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Mont\u00e9gut C, et al. Pre-therapeutic sarcopenia among cancer patients: an up-to-date meta-analysis of prevalence and predictive value during cancer treatment. Nutrients. 2023;15(5):1193. https:\/\/doi.org\/10.3390\/nu15051193.","journal-title":"Nutrients"},{"issue":"7","key":"1925_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335. https:\/\/doi.org\/10.1016\/s1470-2045(08)70153-0.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1925_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1245\/s10434-017-6328-y","volume":"25","author":"S Takamori","year":"2018","unstructured":"Takamori S, Toyokawa G, Okamoto T, Shimokawa M, Kinoshita F, Kozuma Y, et al. Clinical impact and risk factors for skeletal muscle loss after complete resection of early non-small cell lung cancer. Ann Surg Oncol. 2018;25(5):1229\u201336. https:\/\/doi.org\/10.1245\/s10434-017-6328-y.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1925_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00261-020-02751-9","volume":"46","author":"A Qayyum","year":"2021","unstructured":"Qayyum A, Bhosale P, Aslam R, Avritscher R, Ma J, Pagel MD, et al. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. Abdom Radiol (NY). 2021;46(3):1008\u201315. https:\/\/doi.org\/10.1007\/s00261-020-02751-9.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"1925_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-022-09443-1","volume":"22","author":"M Amitani","year":"2022","unstructured":"Amitani M, Oba T, Kiyosawa N, Morikawa H, Chino T, Soma A, et al. Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer. 2022;22(1):327. https:\/\/doi.org\/10.1186\/s12885-022-09443-1.","journal-title":"BMC Cancer"},{"issue":"12","key":"1925_CR12","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.1245\/s10434-023-13840-6","volume":"30","author":"UM Jogiat","year":"2023","unstructured":"Jogiat UM, Baracos V, Turner SR, Eurich D, Filafilo H, Rouhi A, et al. Changes in sarcopenia status predict survival among patients with resectable esophageal cancer. Ann Surg Oncol. 2023;30(12):7412\u201321. https:\/\/doi.org\/10.1245\/s10434-023-13840-6.","journal-title":"Ann Surg Oncol"},{"key":"1925_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16681","author":"WL Lin","year":"2024","unstructured":"Lin WL, Nguyen TH, Huang WT, Guo HR, Wu LM. Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1111\/jgh.16681.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1925_CR14","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.clnu.2020.09.017","volume":"40","author":"M Findlay","year":"2021","unstructured":"Findlay M, White K, Stapleton N, Bauer J. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis. Clin Nutr. 2021;40(4):1711\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2020.09.017.","journal-title":"Clin Nutr"},{"issue":"8","key":"1925_CR15","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1007\/s00405-023-08014-9","volume":"280","author":"E Erul","year":"2023","unstructured":"Erul E, Guven DC, Onur MR, Yazici G, Aksoy S. Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives. Eur Arch Otorhinolaryngol. 2023;280(8):3541\u201356. https:\/\/doi.org\/10.1007\/s00405-023-08014-9.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"1925_CR16","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1002\/hed.25938","volume":"41","author":"RT Karsten","year":"2019","unstructured":"Karsten RT, Al-Mamgani A, Bril SI, Tjon AJS, van der Molen L, de Boer JP, et al. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer. Head Neck. 2019;41(11):4000\u20138. https:\/\/doi.org\/10.1002\/hed.25938.","journal-title":"Head Neck"},{"issue":"3","key":"1925_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.21053\/ceo.2018.01613","volume":"12","author":"F Ufuk","year":"2019","unstructured":"Ufuk F, Herek D, Y\u00fcksel D. Diagnosis of sarcopenia in head and neck computed tomography: cervical muscle mass as a strong indicator of sarcopenia. Clin Exp Otorhinolaryngol. 2019;12(3):317\u201324. https:\/\/doi.org\/10.21053\/ceo.2018.01613.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"1925_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104771","volume":"108","author":"WZ He","year":"2020","unstructured":"He WZ, Jiang C, Liu LL, Yin CX, Rong YM, Hu WM, et al. Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer. Oral Oncol. 2020;108: 104771. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104771.","journal-title":"Oral Oncol"},{"key":"1925_CR19","doi-asserted-by":"publisher","first-page":"175883592094761","DOI":"10.1177\/1758835920947612","volume":"12","author":"X Hua","year":"2020","unstructured":"Hua X, Liao JF, Huang X, Huang HY, Wen W, Long ZQ, et al. Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma. Ther Adv Med Oncol. 2020;12:1758835920947612. https:\/\/doi.org\/10.1177\/1758835920947612.","journal-title":"Ther Adv Med Oncol"},{"issue":"5","key":"1925_CR20","doi-asserted-by":"publisher","first-page":"E1524","DOI":"10.1002\/lary.29165","volume":"131","author":"K Endo","year":"2021","unstructured":"Endo K, Ueno T, Hirai N, Komori T, Nakanishi Y, Kondo S, et al. Low skeletal muscle mass is a risk factor for aspiration pneumonia during chemoradiotherapy. Laryngoscope. 2021;131(5):E1524-e1529. https:\/\/doi.org\/10.1002\/lary.29165.","journal-title":"Laryngoscope"},{"issue":"1","key":"1925_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.clnu.2020.05.020","volume":"40","author":"X Huang","year":"2021","unstructured":"Huang X, Lv LN, Zhao Y, Li L, Zhu XD. Is skeletal muscle loss associated with chemoradiotherapy toxicity in nasopharyngeal carcinoma patients? A prospective study. Clin Nutr. 2021;40(1):295\u2013302. https:\/\/doi.org\/10.1016\/j.clnu.2020.05.020.","journal-title":"Clin Nutr"},{"issue":"6","key":"1925_CR22","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1007\/s00330-020-07440-1","volume":"31","author":"AT Zwart","year":"2021","unstructured":"Zwart AT, Becker JN, Lamers MJ, Dierckx R, de Bock GH, Halmos GB, et al. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed. Eur Radiol. 2021;31(6):4053\u201362. https:\/\/doi.org\/10.1007\/s00330-020-07440-1.","journal-title":"Eur Radiol"},{"key":"1925_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109904","volume":"188","author":"S Liu","year":"2023","unstructured":"Liu S, Zou Y, Zhong M, Li T, Cao Y, Wang R, et al. Prognostic significance of MRI-defined sarcopenia in patients with nasopharyngeal carcinoma: a propensity score matched analysis of real-world data. Radiother Oncol. 2023;188: 109904. https:\/\/doi.org\/10.1016\/j.radonc.2023.109904.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1925_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-021-08036-8","volume":"21","author":"T He","year":"2021","unstructured":"He T, Yan RN, Chen HY, Zeng YY, Xiang ZZ, Liu F, et al. Comparing the 7th and 8th editions of UICC\/AJCC staging system for nasopharyngeal carcinoma in the IMRT era. BMC Cancer. 2021;21(1):327. https:\/\/doi.org\/10.1186\/s12885-021-08036-8.","journal-title":"BMC Cancer"},{"issue":"6","key":"1925_CR25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jamaoncol.2015.6339","volume":"2","author":"AJ Grossberg","year":"2016","unstructured":"Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, et al. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol. 2016;2(6):782\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2015.6339.","journal-title":"JAMA Oncol"},{"key":"1925_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","volume":"62","author":"JE Swartz","year":"2016","unstructured":"Swartz JE, Pothen AJ, Wegner I, Smid EJ, Swart KM, de Bree R, et al. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol. 2016;62:28\u201333. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.09.006.","journal-title":"Oral Oncol"},{"issue":"11","key":"1925_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278135","volume":"17","author":"N Jovanovic","year":"2022","unstructured":"Jovanovic N, Chinnery T, Mattonen SA, Palma DA, Doyle PC, Theurer JA. Sarcopenia in head and neck cancer: a scoping review. PLoS ONE. 2022;17(11): e0278135. https:\/\/doi.org\/10.1371\/journal.pone.0278135.","journal-title":"PLoS ONE"},{"issue":"1","key":"1925_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","volume":"126","author":"AW Lee","year":"2018","unstructured":"Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, et al. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2018;126(1):25\u201336. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.032.","journal-title":"Radiother Oncol"},{"key":"1925_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.682052","volume":"12","author":"MD Zumbaugh","year":"2021","unstructured":"Zumbaugh MD, Yen CN, Bodmer JS, Shi H, Gerrard DE. Skeletal muscle O-GlcNAc transferase action on global metabolism is partially mediated through interleukin-15. Front Physiol. 2021;12: 682052. https:\/\/doi.org\/10.3389\/fphys.2021.682052.","journal-title":"Front Physiol"},{"issue":"8","key":"1925_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.18632\/aging.100482","volume":"4","author":"CT Lutz","year":"2012","unstructured":"Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4(8):535\u201346. https:\/\/doi.org\/10.18632\/aging.100482.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"1925_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","volume":"23","author":"L Pedersen","year":"2016","unstructured":"Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 2016;23(3):554\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2016.01.011.","journal-title":"Cell Metab"},{"issue":"4","key":"1925_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/hed.26978","volume":"44","author":"MA Mascarella","year":"2022","unstructured":"Mascarella MA, Patel T, Vendra V, Gardiner L, Kergoat MJ, Kubik MW, et al. Poor treatment tolerance in head and neck cancer patients with low muscle mass. Head Neck. 2022;44(4):844\u201350. https:\/\/doi.org\/10.1002\/hed.26978.","journal-title":"Head Neck"},{"issue":"15","key":"1925_CR33","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.3390\/ijms22158058","volume":"22","author":"SR Iyer","year":"2021","unstructured":"Iyer SR, Shah SB, Lovering RM. The neuromuscular junction: roles in aging and neuromuscular disease. Int J Mol Sci. 2021;22(15):8058. https:\/\/doi.org\/10.3390\/ijms22158058.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1925_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.clnu.2017.07.010","volume":"37","author":"F Pamoukdjian","year":"2018","unstructured":"Pamoukdjian F, Bouillet T, L\u00e9vy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr. 2018;37(4):1101\u201313. https:\/\/doi.org\/10.1016\/j.clnu.2017.07.010.","journal-title":"Clin Nutr"},{"issue":"1","key":"1925_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13293-021-00361-8","volume":"12","author":"WZ Li","year":"2021","unstructured":"Li WZ, Lv SH, Liu GY, Liang H, Xia WX, Xiang YQ. Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival. Biol Sex Differ. 2021;12(1):18. https:\/\/doi.org\/10.1186\/s13293-021-00361-8.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"1925_CR36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1186\/s12885-023-11564-0","volume":"23","author":"L Cui","year":"2023","unstructured":"Cui L, Chen Z, Zeng F, Jiang X, Han X, Yuan X, et al. Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma. BMC Cancer. 2023;23(1):1146. https:\/\/doi.org\/10.1186\/s12885-023-11564-0.","journal-title":"BMC Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01925-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T12:37:35Z","timestamp":1739104655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01925-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1925"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01925-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,9]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The waiver for informed consent and the study design was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, China (No.: 2024-E509-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}